Latest Breaking News On - Eliem therapeutics - Page 1 : comparemela.com

Eliem Therapeutics, Inc. (NASDAQ:ELYM – Get Free Report) saw a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 128,800 shares, a growth of 127.2% from the April 30th total of 56,700 shares. Currently, 0.7% of the shares of the stock are short sold. Based […]

United statesEliem therapeutics incCapital managementEliem therapeutics company profileEliem therapeuticsGet free reportTherapeutics trading downFree reportEliem therapeutics daily